DEVICE CATEGORY · SGU
Neurovascular Liquid Embolic Agent
Arterial occlusion of the middle meningeal artery for treatment of symptomatic subdural hematoma.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
SQUID Liquid Embolic Agent (LEA)P250009/S001 | Balt USA, LLC | PMA supplement | Oct 16, 2026 | FDA |
SQUID Liquid Embolic Agent (LEA)P250009/S002 | Balt USA, LLC | PMA supplement | Sep 9, 2026 | FDA |
Onyx Liquid Embolic System (LES)P030004/S042 | Ev3 Neurovascular | PMA supplement | Aug 5, 2026 | FDA |
| Balt USA, LLC | PMA approval | Jan 30, 2026 | FDA | |
| Cerenovus, Inc. | PMA supplement | Dec 16, 2025 | FDA | |
Onyx Liquid Embolic System (LES)P030004/S035 | Ev3 Neurovascular | PMA supplement | Dec 8, 2025 | FDA |
Source information
Follow the FDA links to view the original records.




